Quality Criteria and Standardization of Phytopharmaceuticals: Can Acceptable Drug Standards Be Achieved?

被引:0
|
作者
Rudolf Bauer
机构
[1] Heinrich-Heine-Universität Düsseldorf,Institute of Pharmaceutical Biology
关键词
Phytopharmaceuticals; Quality; Standardization;
D O I
暂无
中图分类号
学科分类号
摘要
Phytopharmaceuticals are composed of many constituents and are therefore very capable of variation. The variability of the plant material is due to different growth, harvest, drying, and storage conditions. Therefore, cultivation of the plants under standardized conditions is desirable. The polarity of the solvent, the mode of extraction, and the instability of constituents may also influence the composition and quality of the extracts and must therefore be kept constant. The quality criteria for herbal drugs are based on a clear scientific definition of the raw material. Depending on the type of preparation, sensoric features, moisture, ash, physical constants, solvent residues, and adulterations have to be checked to prove identity and purity. Microbiological contamination and foreign materials, such as heavy metals, pesticide residues, aflatoxins, and radioactivity are further criteria to be tested.
引用
收藏
页码:101 / 110
页数:9
相关论文
共 50 条
  • [21] Can acceptable pregnancy rates be achieved using exclusive timed artificial insemination for first service?
    Capel, M. B.
    Nydam, D. V.
    Saltman, R.
    JOURNAL OF ANIMAL SCIENCE, 2004, 82 : 258 - 258
  • [23] Quality assurance for multiplexed assays - how can it be achieved?
    Kricka, Larry J.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2016, 76 : S100 - S103
  • [24] Can acceptable pregnancy rates be achieved using exclusive timed artificial insemination for first service?
    Capel, M. B.
    Nydam, D. V.
    Saltman, R.
    POULTRY SCIENCE, 2004, 83 : 258 - 258
  • [25] Standards and standardization in mastocytosis:: Consensus statements on diagnostics, treatment recommendations and response criteria
    Valent, P.
    Akin, C.
    Escribano, L.
    Foedinger, M.
    Hartmann, K.
    Brockow, K.
    Castells, M.
    Sperr, W. R.
    Kluin-Nelemans, H. C.
    Hamdy, N. A. T.
    Lortholary, O.
    Robyn, J.
    van Doormaal, J.
    Sotlar, K.
    Hauswirth, A. W.
    Arock, M.
    Hermine, O.
    Hellmann, A.
    Triggiani, M.
    Niedoszytko, M.
    Schwartz, L. B.
    Orfao, A.
    Horny, H.-P.
    Metcalfe, D. D.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2007, 37 (06) : 435 - 453
  • [26] Benefits of high quality data and how this can be achieved
    Nave, C.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2000, 56 : S104 - S104
  • [27] Bilirubin measurements in neonates: uniform neonatal treatment can only be achieved by improved standardization
    Hulzebos, Christian V.
    Camara, Johanna E.
    van Berkel, Miranda
    Delatour, Vincent
    Lo, Stanley F.
    Mailloux, Agnes
    Schmidt, Marcel C.
    Thomas, Mercy
    Mackay, Lindsey G.
    Greaves, Ronda F.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2024, 62 (10) : 1892 - 1903
  • [28] Can quasi-quality be a consequence of quality standards?
    Slagsvold, B
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 1999, 32 (02): : 213 - 213
  • [29] Drug testing, quality control, and standards
    Purves, J
    NOVEL SYSTEMS FOR THE STUDY OF HUMAN DISEASE: FROM BASIC RESEARCH TO APPLICATIONS, 1998, : 345 - 351
  • [30] How can minimal standards be achieved in primary care referrals to specialist care?
    Behal, M.
    Burdenw, A. C. F.
    DIABETIC MEDICINE, 2008, 25